Travere Therapeutics (TVTX) Cash & Equivalents (2013 - 2026)
Travere Therapeutics' Cash & Equivalents was $117.74 million in Q2 2026, up 56.7% from $75.15 million a year earlier and up 50.2% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Travere Therapeutics came in at $93.04 million, up 58.9% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 1.9% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $58.54 million in FY2024 (+0.6%), $58.18 million in FY2023 (-5.7%), $61.69 million in FY2022 (-62.8%) and $165.75 million in FY2021 (+95.5%).
- The Q2 2026 figure marks the highest quarterly Cash & Equivalents since Q3 2023.
- Compared with a year earlier, Cash & Equivalents has increased for seven straight quarters, with growth averaging 56.1% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2025 (growth of 204.7%); the worst was Q3 2024 (a decline of 74.8%).
- Per Business Quant data, TVTX's Cash & Equivalents in the three quarters before Q2 2026 was $78.36 million (Q1 2026), $93.04 million (Q4 2025) and $110.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Travere Therapeutics | 5.36 Bn | 4.96 Bn | 167.41 Mn | 117.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 117.74 Mn |
| Mar 31, 2026 | 78.36 Mn |
| Dec 31, 2025 | 93.04 Mn |
| Sep 30, 2025 | 110.93 Mn |
| Jun 30, 2025 | 75.15 Mn |
| Mar 31, 2025 | 61.90 Mn |
| Dec 31, 2024 | 58.54 Mn |
| Sep 30, 2024 | 36.41 Mn |
| Jun 30, 2024 | 32.29 Mn |
| Mar 31, 2024 | 43.25 Mn |
| Dec 31, 2023 | 58.18 Mn |
| Sep 30, 2023 | 144.24 Mn |
| Jun 30, 2023 | 70.87 Mn |
| Mar 31, 2023 | 161.38 Mn |
| Dec 31, 2022 | 61.69 Mn |
| Sep 30, 2022 | 151.34 Mn |
| Jun 30, 2022 | 179.76 Mn |
| Mar 31, 2022 | 256.57 Mn |
| Dec 31, 2021 | 165.75 Mn |
| Sep 30, 2021 | 150.33 Mn |
API Access
Travere Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();